跳至主要内容
临床试验/NCT03153566
NCT03153566Unknown3 期

Comparison Between Tuberculin Vaccine and Cryotherapy in the Treatment of Genital Wart Patients

Assiut University0 个研究点目标入组 45 人开始时间: 2017年6月1日最近更新:
适应症

试验速览

阶段
3 期
入组人数
45
主要终点
number of patients with complete resolution of genital warts

研究概览

简要总结

Cutaneous and genital warts are common dermatological conditions caused by Human Papilloma Virus. Although it is a benign condition it causes disfigurement, has tendency to collect, can be transmitted to others, this makes adequate and timely treatment important, while many warts are resolve spontaneously over several years, most patients seek treatment because the warts are unsightly and often tender or painful.

详细描述

Genital warts are highly contagious sexually transmitted diseases (STD) caused by infection of Human Papilloma Virus and, as the most common STD in developed countries, can currently be considered to be globally epidemic.

It is estimated that the frequency of Human Papilloma Virus infection among women in the world ranges from 2% to 44%.

The conventional modalities in treatment of warts include destructive therapies such as salicylic acid, trichloroacetic acid, cryotherapy, silver nitrate, phenol, cantharidin, surgical interventions and laser, antiproliferative agents such as bleomycin, vitamin D analogs, podophyllin, 5 fluorouracil and antiviral agents such as cidofovir and retinoids.

There are different mechanisms have been proposed for the resolution of warts with skin test antigens such as mumps, candida, trichophyton both at the injected as well as distant sites.

Tuberculin:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • All types of genital and anal warts will be included in this study especially patients with 5 or more warts and more than 1 cm in size

排除标准

  • Patients with immunodeficient diseases or receiving any immunosuppressive drugs
  • Pregnancy and lactation

结局指标

主要结局

number of patients with complete resolution of genital warts

时间窗: 4 months

frequency (number)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mena Ramsis Haleem

Principal Investigator

Assiut University

相似试验

Comparison Between Tuberculin Vaccine and... | 临床试验